287 related articles for article (PubMed ID: 2579437)
1. Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R; Losito C
Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
[No Abstract] [Full Text] [Related]
2. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
3. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
4. [Low molecular weight heparins].
Kher A; Bara L; Samama M
Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
[TBL] [Abstract][Full Text] [Related]
5. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
Aiach M; Roncato M
Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
[No Abstract] [Full Text] [Related]
7. Development of heparin fractions: some overlooked considerations.
Fareed J
Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
[No Abstract] [Full Text] [Related]
8. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
Fareed J
Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of a heparinoid derived from pentosan].
Lansen J; Diner H
Agressologie; 1983 Dec; 24(12):591-5. PubMed ID: 6199994
[No Abstract] [Full Text] [Related]
11. Heparin, heparin fractions, and the atherosclerotic process.
Engelberg H
Semin Thromb Hemost; 1985 Jan; 11(1):48-55. PubMed ID: 3883499
[No Abstract] [Full Text] [Related]
12. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
14. Experimental and clinical pharmacology of pentosan polysulfate.
Maffrand JP; Herbert JM; Bernat A; Defreyn G; Delebassee D; Savi P; Pinot JJ; Sampol J
Semin Thromb Hemost; 1991; 17 Suppl 2():186-98. PubMed ID: 1719639
[No Abstract] [Full Text] [Related]
15. From heparin to heparin fractions and derivatives.
Coyne E
Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
[No Abstract] [Full Text] [Related]
16. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
Choay J
Semin Thromb Hemost; 1985 Apr; 11(2):81-5. PubMed ID: 4035368
[TBL] [Abstract][Full Text] [Related]
17. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
[TBL] [Abstract][Full Text] [Related]
18. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
Ryde M; Eriksson H; Tangen O
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
[No Abstract] [Full Text] [Related]
19. Biochemical and pharmacological studies on the interaction of PK 10169 and its subfractions with human platelets.
Brace LD; Fareed J; Tomeo J; Issleib S
Haemostasis; 1986; 16(2):93-105. PubMed ID: 3710299
[TBL] [Abstract][Full Text] [Related]
20. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.
Bratt G; Törnebohm E; Lockner D; Bergström K
Thromb Haemost; 1985 Apr; 53(2):208-11. PubMed ID: 4024029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
